Since PI3K/Akt/mTOR pathway inhibition is reported to decrease invasion and migration of ovarian carcinoma cell lines [25,26], thus PPL siRNA potentially decreased cellular attachment, migration or movement at least partly via the PI3K/Akt axis. The gene discussed is PPL; the disease is ovarian carcinoma.